177 related articles for article (PubMed ID: 5626247)
21. Fibrin deposition in the ribbit kidney produced by protease inhibitors.
Beller FK; Mitchell PS; Gorstein F
Thromb Diath Haemorrh; 1967 May; 17(3-4):427-39. PubMed ID: 5301528
[No Abstract] [Full Text] [Related]
22. [Activation of euglobulin lysis induced by Atheroid (R)].
Prino G; Mantovani M; Butti A
Boll Soc Ital Biol Sper; 1969 Jan; 45(2):133-7. PubMed ID: 5346780
[No Abstract] [Full Text] [Related]
23. [The modification of the effect of trypsin on blood coagulation by natural and synthetic trypsin and thrombin inhibitors].
Landman H; Markwardt F; Perlewitz J
Thromb Diath Haemorrh; 1969 Dec; 22(3):552-68. PubMed ID: 5382290
[No Abstract] [Full Text] [Related]
24. Clot life span model analysis of clot growth and fibrinolysis in normal subjects: role of thrombin activatable fibrinolysis inhibitor.
Nielsen VG
Blood Coagul Fibrinolysis; 2008 Jun; 19(4):283-7. PubMed ID: 18469549
[TBL] [Abstract][Full Text] [Related]
25. Retinoic acid enhances fibrinolytic activity in-vivo by enhancing tissue type plasminogen activator (t-PA) activity and inhibits venous thrombosis.
van Giezen JJ; Boon GI; Jansen JW; Bouma BN
Thromb Haemost; 1993 Apr; 69(4):381-6. PubMed ID: 8497851
[TBL] [Abstract][Full Text] [Related]
26. [Characterization of a trypsin-like proteinase (acrosin) from boar spermatozoa by inhibition with different protein proteinase inhibitors, II. Inhibitors from leeches, soybeans, peanuts, bovine colostrum and sea anemones].
Fritz H; Förg-Brey B; Schiessler H; Arnhold M; Fink E
Hoppe Seylers Z Physiol Chem; 1972 Jun; 353(6):1010-2. PubMed ID: 4403328
[No Abstract] [Full Text] [Related]
27. [The effect of peanuts (Arachis hypogaea) and peanut extracts on coagulation factors].
SCHMUTZLER R
Thromb Diath Haemorrh; 1961 Apr; 5():566-75. PubMed ID: 13748167
[No Abstract] [Full Text] [Related]
28. Elastic modulus-based thrombelastographic quantification of plasma clot fibrinolysis with progressive plasminogen activation.
Nielsen VG; Cohen BM; Cohen E
Blood Coagul Fibrinolysis; 2006 Jan; 17(1):75-81. PubMed ID: 16607085
[TBL] [Abstract][Full Text] [Related]
29. Clot structure modification by fondaparinux and consequence on fibrinolysis: a new mechanism of antithrombotic activity.
Varin R; Mirshahi S; Mirshahi P; Kierzek G; Sebaoun D; Mishal Z; Vannier JP; Yvonne Borg J; Simoneau G; Soria C; Soria J
Thromb Haemost; 2007 Jan; 97(1):27-31. PubMed ID: 17200767
[TBL] [Abstract][Full Text] [Related]
30. Experimental production of microangiopathic haemolytic anaemia in vivo.
Rubenberg ML; Bull BS; Regoeczi E; Dacie JV; Brain MC
Lancet; 1967 Nov; 2(7526):1121-3. PubMed ID: 4168559
[No Abstract] [Full Text] [Related]
31. [Effect and mechanism of recombinant hirudin on fibrinolysis].
Li M; Zhang RJ; Cao GX; Wan WX; Zhang LF; Jin J
Yao Xue Xue Bao; 2006 Sep; 41(9):814-8. PubMed ID: 17111825
[TBL] [Abstract][Full Text] [Related]
32. Resistance of porcine blood clots to lysis relates to poor activation of porcine plasminogen by tissue plasminogen activator.
Flight SM; Masci PP; Lavin MF; Gaffney PJ
Blood Coagul Fibrinolysis; 2006 Jul; 17(5):417-20. PubMed ID: 16788320
[TBL] [Abstract][Full Text] [Related]
33. Effects of ellagic acid upon the human fibrinolytic system.
Iatridis SG; Iatridis PG; Ferguson JH
Thromb Diath Haemorrh; 1966 Dec; 16(3):656-67. PubMed ID: 4231538
[No Abstract] [Full Text] [Related]
34. The inhibition of tissue plasminogen activator and urokinase-induced fibrinolysis by some natural proteinase inhibitors and by plasma and serum from normal and pregnant subjects.
Thorsen S
Scand J Clin Lab Invest; 1973 Jan; 31(1):51-9. PubMed ID: 4687777
[No Abstract] [Full Text] [Related]
35. A multiparameter test of clot formation and fibrinolysis for in-vitro drug screening.
Kostka B; Para J; Sikora J
Blood Coagul Fibrinolysis; 2007 Oct; 18(7):611-8. PubMed ID: 17890947
[TBL] [Abstract][Full Text] [Related]
36. Hydroxyethyl starch enhances fibrinolysis in human plasma by diminishing alpha2-antiplasmin-plasmin interactions.
Nielsen VG
Blood Coagul Fibrinolysis; 2007 Oct; 18(7):647-56. PubMed ID: 17890952
[TBL] [Abstract][Full Text] [Related]
37. [Effect of aortic extracts on blood coagulation and fibrinolysis].
Papilian M; Velican C; Leahu S
Stud Cercet Med Interna; 1969; 10(5):431-8. PubMed ID: 5370603
[No Abstract] [Full Text] [Related]
38. Effects of low-density lipoproteins on blood coagulation and fibrinolytic activity.
Azizova OA; Roitman EV; Dement'eva II; Nikitina NA; Gagaeva EV; Lopukhin YM
Bull Exp Biol Med; 2000 Jun; 129(6):541-4. PubMed ID: 11022243
[TBL] [Abstract][Full Text] [Related]
39. [Coagulation and fibrinolysis during treatment with a monoamine oxidase inhibitor (hydrazinoxan). Clinico-experimental findings].
Craveri A
Minerva Med; 1965 Sep; 56(73):3035-9. PubMed ID: 5835985
[No Abstract] [Full Text] [Related]
40. [Studies in the benzofuran series. LV. Fibrinolytic properties of inicarone].
Barchewitz G; Brotelle R; Guilbert A; Charlier R
Therapie; 1974; 29(1):57-70 passim. PubMed ID: 4849779
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
